Miromatrix moves into new headquarters, adding production capacity for bioengineered organs By: Minneapolis / St. Paul Business Journal via Business Journals March 30, 2022 at 07:15 AM EDT The new space gives the company room to manufacture organs for pre-clinical and clinical trials. Read More >> Related Stocks: Harbor Disruptive Innovation ETF
